FrancophonIA/ELRC3.0 huggingface dataset:
English: Left ventricular ejection fraction (LVEF) decreases have been reported in approximately 1% of patients receiving lapatinib and were asymptomatic in more than 70% of cases.
Slovenian: O zmanjšanju iztisnega deleža levega prekata (LVEF; “left ventricular ejection fraction”) so poročali pri približno 1 % bolnikov, ki so se zdravili z lapatinibom.
English: No additional adverse reactions were reported to be associated with lapatinib in combination with trastuzumab.
Slovenian: Ni opisano, da bi bili z lapatinibom v kombinaciji s trastuzumabom povezani kakšni dodatni neželeni učinki.
English: OUTER CARTON (28-DAY, MULTIPACK)
Slovenian: ŠKATLA (PAKIRANJE PO VEČ ENOT ZA 28-DNEVNO ZDRAVLJENJE)
English: If you are prescribed Tyverb in combination with trastuzumab, the usual dose is 4 Tyverb tablets a day, as a single dose.
Slovenian: Če vam je zdravnik zdravilo Tyverb predpisal v kombinaciji s trastuzumabom, je običajen odmerek 4 tablete zdravila Tyverb na dan, uporabljenih hkrati.
English: If you are prescribed Tyverb in combination with capecitabine, the usual dose is 5 Tyverb tablets a day, as a single dose.
Slovenian: Če vam je zdravnik zdravilo Tyverb predpisal v kombinaciji s kapecitabinom, je običajen odmerek 5 tablet zdravila Tyverb na dan, uporabljenih hkrati.
English: Tyverb / aromatase inhibitor combination posology
Slovenian: Odmerjanje kombinacije Tyverb/zaviralec aromataze
English: An increase in the incidence and severity of diarrhoea and neutropenia has been observed with this combination in clinical studies.
Slovenian: Med uporabo te kombinacije so v kliničnih študijah opažali večjo incidenco in izrazitost driske in nevtropenije.
English: The recommended dose of Tyverb is 1500 mg (i.e. six tablets) once daily continuously.
Slovenian: Priporočeni odmerek je 1.500 mg zdravila Tyverb (tj. šest tablet) enkrat na dan, neprekinjeno.
English: Lapatinib inhibits CYP2C8 in vitro at clinically relevant concentrations.
Slovenian: Lapatinib in vitro pri klinično pomembnih koncentracijah zavira CYP2C8.
English: Median PFS, weeks (95% CI) Hazard ratio 0.71 (0.53, 0.96) P-value Objective response rate (ORR) Odds ratio 0.4 (0.2, 0.9) P-value Clinical benefit rate (CBR) Odds ratio 0.4 (0.2, 0.8) P-value
Slovenian: Mediano PBN, tedni (95 % IZ) Razmerje tveganj Vrednost p 0,019 Objektivni delež odziva (ODO) Razmerje obetov Vrednost p 0,021 Delež klinične koristi (DKK) Razmerje obetov Vrednost p 0,003 IZ = interval zaupanja čezmerna ekspresija HER2 = IHC 3+ in/ali FISH-pozitivni HER2-negativni = IHC 0, 1+ ali 2+ in/ali FISH-negativni Delež klinične koristi je po definiciji obsegal popoln odziv, delen odziv in  6 mesecev stabilno bolezen.
English: Lapatinib pharmacokinetics have not been specifically studied in patients with renal impairment or in patients undergoing haemodialysis.
Slovenian: Pri bolnikih z okvaro ledvic in bolnikih, ki se zdravijo s hemodializo, farmakokinetike lapatiniba niso posebej preučevali.
English: Each pack of Tyverb contains 70 film-coated tablets in foil blisters (polyamide / aluminium / polyvinyl chloride / aluminium) of 10 tablets each.
Slovenian: Odmerjanje kombinacije zdravila Tyverb/kapecitabin Ena škatla zdravila Tyverb vsebuje 70 filmsko obloženih tablet v pretisnih omotih (poliamid / aluminij / polivinilklorid / aluminij).
English: LVEF decreases were reported in 2.5 % of patients who received lapatinib in combination with capecitabine, as compared to 1.0 % with capecitabine alone.
Slovenian: O zmanjšanju iztisnega deleža levega prekata so poročali pri 2,5 % bolnikov, ki so prejemali lapatinib v kombinaciji s kapecitabinom, v primerjavi z 1,0 % bolnikov, ki so prejemali samo kapecitabin.
English: Tyverb 1500 mg / day + Letrozole 2.5 mg /day
Slovenian: Tyverb 1500 mg/dan + letrozol 2,5 mg/dan letrozol 2,5 mg/dan + placebo
English: Breast-feeding must be discontinued in women who are receiving therapy with Tyverb and for at least 5 days after the last dose.
Slovenian: Med zdravljenjem z zdravilom Tyverb mora ženska prenehati z dojenjem in ne sme dojiti še najmanj 5 dni po zaužitju zadnjega odmerka zdravila.
English: Tyverb may be reintroduced at a lower dose (reduced from 1000 mg/day to 750 mg/day, from 1250 mg/day to 1000 mg/day or from 1500 mg/day to 1250 mg/day) when diarrhoea resolves to grade 1 or less.
Slovenian: Ko se driska zmanjša na stopnjo 1 ali manj, je mogoče zdravilo Tyverb znova uvesti v nižjem odmerku (znižanje s 1.000 mg/dan na 750 mg/dan, s 1.250 mg/dan na 1.000 mg/dan ali s 1.500 mg/dan na 1.250 mg/dan).
English: The incidence of PPE was similar in the lapatinib plus capecitabine and capecitabine alone treatment arms.
Slovenian: Pojavnost PPE je bila v skupinah, ki so prejemale lapatinib v kombinaciji s kapecitabinom, podobna kot v skupinah, ki so prejemale samo kapecitabin.
English: Co-administration of Tyverb with moderate inhibitors of CYP3A4 should proceed with caution and clinical adverse reactions should be carefully monitored.
Slovenian: Pri sočasni uporabi zdravila Tyverb in zmernih zaviralcev CYP3A4 je potrebna previdnost.
English: †, cough
Slovenian: †, pruritus
English: There are no adequate data from the use of Tyverb in women of childbearing potential.
Slovenian: O uporabi zdravila Tyverb pri ženskah v rodni dobi ni dovolj podatkov.
English: Diarrhoea, including severe diarrhoea, has been reported with Tyverb treatment (see section 4.8).
Slovenian: Pri zdravljenju z zdravilom Tyverb so poročali o pojavu driske, vključno s hudo drisko (glejte poglavje 4.8).
English: Lapatinib has been associated with reports of decreases in LVEF (see section 4.8).
Slovenian: Pri uporabi lapatiniba so poročali o zmanjšanju LVEF; “left ventricular ejection fraction” (glejte poglavje 4.8).
English: UNIQUE IDENTIFIER - 2D BARCODE 2D barcode carrying the unique identifier included.
Slovenian: [samo škatla] Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
English: • if you have inflammation of the lung
Slovenian: • če imate vnetje pljuč,
English: Your doctor also needs to know before you take Tyverb:
Slovenian: Pred začetkom jemanja zdravila Tyverb morate svojemu zdravniku povedati tudi:
English: Liver function (transaminases, bilirubin and alkaline phosphatase) should be monitored before the initiation of treatment and monthly thereafter, or as clinically indicated.
Slovenian: Pred uvedbo zdravljenja z lapatinibom je treba ovrednotiti delovanje jeter (transaminaze, bilirubin in alkalna fosfataza).
English: Serious cutaneous reactions have been reported with Tyverb.
Slovenian: Med uporabo zdravila Tyverb so poročali o resnih kožnih reakcijah.
English: OTHER
Slovenian: ND
English: A concentration-dependent increase of the QTc interval was demonstrated in a dedicated placebo-controlled crossover study in subjects with advanced solid tumours.
Slovenian: V za to namenjeni, s placebom kontrolirani navzkrižni študiji pri bolnikih z napredovalimi solidnimi tumorji so dokazali od koncentracije odvisno podaljšanje intervala QTc.
English: Lapatinib inhibits the transport protein Pgp in vitro at clinically relevant concentrations.
Slovenian: Lapatinib in vitro pri klinično pomembnih koncentracijah zavira transportno beljakovino Pgp.
English: No dose adjustment is necessary in patients with mild to moderate renal impairment.
Slovenian: Pri bolnikih z blago do zmerno okvaro ledvic odmerka ni treba prilagajati.
English: There were no effects on male or female rat gonadal function, mating, or fertility at doses up to 120 mg/kg/day (females) and up to 180 mg/kg/day (males) (8 and 3 times the expected human clinical exposure, respectively).
Slovenian: Pri odmerkih do 120 mg/kg/dan (samice) in do 180 mg/kg/dan (samci) (8-kratna oziroma 3-kratna pričakovana izpostavljenost človeka pri klinični uporabi) niso opazili vpliva na delovanje moških ali ženskih spolnih žlez, na parjenje ali na plodnost.
English: Pre-planned OS analysis (conducted at the time of the final PFS analysis, 03 June 2008) Median follow-up (yrs)
Slovenian: Letrozol 2,5 mg/dan + placebo N = 108 Vnaprej načrtovana analiza celokupnega preživetja (izvedena ob času končne analize preživetja brez napredovanja, 03. junija 2008) Mediano spremljanje (leta) Smrti (%) Razmerje ogroženosti a
English: Tell your doctor if any of these side effects get severe or troublesome.
Slovenian: Če katerikoli od teh neželenih učinkov postane resen ali moteč, o tem obvestite svojega zdravnika.
English: Patients were randomised to receive either Tyverb 1250 mg once daily (continuously) plus capecitabine (2000 mg/m2/day on days 1-14 every 21 days), or to receive capecitabine alone
Slovenian: Bolniki so bili randomizirani tako, da so prejemali bodisi zdravilo Tyverb v odmerku 1.250 mg enkrat na dan (neprekinjeno) in kapecitabin (2.000 mg/m2/dan od 1.do 14. dne 21-dnevnega ciklusa) ali pa samo kapecitabin (2.500 mg/m2/dan na 1.-14. dan 21-dnevnega ciklusa).
English: Concomitant treatment with inducers of CYP3A4 should be avoided due to risk of decreased exposure to lapatinib (see section 4.5).
Slovenian: Zaradi tveganja za manjšo izpostavljenost lapatinibu se je treba izogibati sočasnemu zdravljenju z induktorji CYP3A4 (glejte poglavje 4.5).
English: HR (95% CI)
Slovenian: Mediana (95 % IZ)
English: The primary route of excretion for lapatinib and its metabolites is in faeces.
Slovenian: Blato je primarna pot izločanja lapatiniba in njegovih presnovkov.
English: Concomitant treatment with strong inhibitors of CYP3A4 should be avoided due to risk of increased exposure to lapatinib (see section 4.5).
Slovenian: Zaradi tveganja za večjo izpostavljenost lapatinibu se je treba izogibati sočasnemu zdravljenju z močnimi zaviralci CYP3A4 (glejte poglavje 4.5).
English: Investigator assessment Tyverb (1250 mg/day)+ capecitabine (2000 mg/m2/day,
Slovenian: Ocena raziskovalcev Tyverb (1.250 mg/dan) + kapecitabin (2.000 mg/m2/dan, od 1. do 14. dne 21-dnevnega ciklusa)
English: • If you are breast-feeding or planning to breast-feed, tell your doctor.
Slovenian: • Če dojite ali nameravate dojiti, to povejte svojemu zdravniku.
English: Tyverb can cause skin rash
Slovenian: Zdravilo Tyverb lahko povzroči izpuščaj na koži.
English: Tyverb dosing should be discontinued if changes in liver function are severe and patients should not be retreated.
Slovenian: Če so spremembe v delovanju jeter hude, je treba zdravljenje z zdravilom Tyverb prekiniti.
English: Lapatinib has in terms of objective responses demonstrated modest activity in the treatment of established CNS metastases.
Slovenian: Vpliv lapatiniba na metastaze v osrednjem živčevju Kar zadeva objektivne izide, je bila aktivnost lapatiniba pri zdravljenju že nastalih metastaz v osrednjem živčevju zmerna.
English: • treatment-induced lung inflammation, which may cause shortness of breath or cough Tell your doctor immediately if you get either of these symptoms.
Slovenian: • z zdravljenjem povzročeno vnetje pljuč, ki lahko povzroči težave z dihanjem ali kašelj.
English: Hyperbilirubinaemia, hepatotoxicity (see section 4.4).
Slovenian: Bolezni jeter, žolčnika in žolčevodov Pogosti hiperbilirubinemija, hepatotoksičnost (glejte poglavje 4.4) Bolezni kože in podkožja
English: Tell your doctor as soon as possible if you get any of these symptoms.
Slovenian: Če se vam pojavi kateri od teh simptomov, o tem čim prej obvestite zdravnika.
English: While you are taking Tyverb
Slovenian: Med jemanjem zdravila Tyverb
English: Tyverb / capecitabine combination posology
Slovenian: Odmerjanje kombinacije Tyverb/kapecitabin
English: • joint or back pain
Slovenian: • bolečine v sklepih ali hrbtu,
English: • St John's Wort - a herb extract used to treat depression
Slovenian: • šentjanževka - rastlinski izvleček, ki ga uporabljamo pri zdravljenju depresije,
English: How to store Tyverb
Slovenian: Shranjevanje zdravila Tyverb
English: Skin and subcutaneous tissue disorders Very common Rash (including dermatitis acneiform) (see section 4.2 - dose delay and dose reduction - other toxicities), dry skin* †, palmar-plantar erythrodysaesthesia*, alopecia †, pruritus
Slovenian: Zelo pogosti izpuščaj (vključno z akneiformnim dermatitisom) (glejte poglavje 4.2Odložitev zdravljenja in zmanjšanje odmerka - Drugi toksični učinki), suha koža*
English: Tyverb / trastuzumab combination posology
Slovenian: Odmerjanje kombinacije Tyverb/trastuzumab
English: When clinically indicated, e.g. after initiation of a concomitant treatment that might affect QT or that may interact with lapatinib, ECG measurement should also be considered.
Slovenian: Pred začetkom in en do dva tedna po začetku zdravljenja z zdravilom Tyverb je treba kontrolirati elektrokardiogram in opraviti merjenje intervala QT. O kontroli elektrokardiograma je treba razmisliti tudi v primerih, ko je to klinično indicirano, npr. po uvedbi sočasnega zdravljenja, ki lahko vpliva na interval QT ali pri katerem lahko pride do medsebojnega delovanja z lapatinibom.
English: Tell your doctor immediately if you get any of these symptoms.
Slovenian: Če opazite katerega koli od teh simptomov, o tem nemudoma obvestite svojega zdravnika.
English: Elderly
Slovenian: Driska
English: Tell your doctor if any of these apply to you.
Slovenian: Če se karkoli od navedenega nanaša na vas, o tem obvestite svojega zdravnika.
English: Reducing the risk of diarrhoea and skin rash
Slovenian: Zmanjšanje tveganja driske in izpuščaja na koži Zdravilo Tyverb lahko povzroči hudo drisko.
English: Dosing can be restarted, when the toxicity improves to grade 1 or less, at 1000 mg/day when administered with trastuzumab,
Slovenian: Ko se znaki toksičnosti izboljšajo na stopnjo 1 ali manjšo, se lahko zdravljenje ponovno uvede, in sicer v odmerku 1.000 mg/dan, če je uporabljen s trastuzumabom, 1.250 mg/dan, če je zdravilo uporabljeno s kapecitabinom,1.500 mg/dan, če je uporabljeno z zaviralcem aromataze.
English: Tell your doctor if you are taking, or have recently taken, any of these.
Slovenian: Če jemljete ali ste pred kratkim jemali katero koli od teh zdravil, obvestite svojega zdravnika.
English: Caution is advised if lapatinib is co-administered with paclitaxel.
Slovenian: Ob sočasni uporabi lapatiniba in paklitaksela je potrebna previdnost.
English: Hampshire RG24 9NL United Kingdom
Slovenian: Hampshire RG24 9NL Združeno Kraljestvo
English: The safety of the veterinary medicinal product has not been established during pregnancy and lactation (see section 4.3).
Slovenian: Varnost zdravila za uporabo v veterinarski medicini v obdobju brejosti in laktacije ni bila ugotovljena (glejte razdelek 4.3).
English: Dispose of waste material in accordance with local requirements.
Slovenian: Odpadni material odvrzite v skladu z lokalnimi predpisi.
English: Do not use in dogs less than 6 weeks of age.
Slovenian: Ne uporabite pri psih, mlajših od 6 tednov starosti.
English: These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Slovenian: Našteti neželeni učinki so najpogostnejši prvi teden zdravljenja, so večinoma prehodni in po končanem zdravljenju izzvenijo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
English: 1 mg For a full list of excipients, see section 6.1.
Slovenian: 1 mg Za celoten seznam pomožnih snovi, glejte poglavje 6.1.
English: The syringe should be stored in the carton box in between uses.
Slovenian: Brizgalka mora biti v času med posameznimi uporabami shranjena v kartonski škatli.
English: Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids (oxicams), ATCvet code: QM01AC06
Slovenian: Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
English: PHARMACEUTICAL FORM Oral suspension.
Slovenian: FARMACEVTSKA OBLIKA Peroralna suspenzija.
English: The volume of distribution is 0.3 1/kg.
Slovenian: Porazdelitveni volumen je 0,3 l/kg.
English: Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 6.1 hours.
Slovenian: Meloksikam se po peroralnem dajanju povsem absorbira in doseže največje koncentracije v plazmi po približno 6,1 ure.
English: SPECIAL WARNING(S), IF NECESSARY Do not use in pregnant or lactating dogs
Slovenian: POSEBNO(A) OPOZORILO(A), ČE JE/SO POTREBNO(A) Ne uporabljajte pri brejih ali doječih psicah.
English: Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Slovenian: Druga nesteroidna protivnetna zdravila, diuretiki, antikoagulanti, aminoglikozidni antibiotiki in snovi z visoko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko privede do toksičnih učinkov.
English: Pull the plunger out until the black on the plunger corresponds to your dog's bodyweight in kilograms.
Slovenian: Bat od brizgalke izvlecite, tako da se črna črta na njem ujema s telesno maso psa v kilogramih.
English: White to yellowish opaque suspension.
Slovenian: Neprozorna bela do rumenkasta suspenzija.
English: If adverse reactions occur, treatment should be discontinued and the advice of the veterinarian should be sought.
Slovenian: Če se pojavijo neželeni učinki, je treba zdravljenje prekiniti in se posvetovati z veterinarjem.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 14.11.2007
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet:14/11/2007
English: Marketing authorisation holder: Eli Lilly and Company Limited Elanco Animal Health Lilly House, Priestley Road Basingstoke
Slovenian: Imetnik dovoljenja za promet z zdravilom Eli Lilly and Company Limited Elanco Animal Health Lilly House, Priestley Road Basingstoke
English: To be administered with food.
Slovenian: Dajati s hrano.
English: ADVICE ON CORRECT ADMINISTRATION Particular care should be taken with regard to the accuracy of dosing.
Slovenian: NASVET O PRAVILNI UPORABI ZDRAVILA Posebno skrbno je treba paziti na natančno odmerjanje zdravila.
English: Approximately 75 % of the administered dose of meloxicam is eliminated via faeces and the remainder via urine.
Slovenian: Približno 75 % vnesenega odmerka se izloči z blatom, preostanek pa z urinom.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA En ml vsebuje:
English: For longer term treatment once clinical response has been observed (after 4 or more days), the dose of Meloxivet can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
Slovenian: Za dolgotrajnejše zdravljenje lahko, ko se pokaže klinični odziv (po 4 ali več dneh), odmerek Meloxivet prilagodimo, tako da določimo najmanjši učinkoviti individualni odmerek ob upoštevanju, da se lahko jakost bolečine in vnetja pri kroničnih mišično-skeletnih obolenjih s časom spreminjata.
English: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Slovenian: Meloksikam je nesteroidno protivnetno zdravilo (NSAR) iz skupine oksikamov, ki zavira sintezo prostaglandinov in tako deluje protivnetno, analgetično, antieksudativno in antipiretično.
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary In case of overdose symptomatic treatment should be initiated.
Slovenian: 4.10 Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) Pri nenamernem vnosu prevelikega odmerka uvedemo simptomatsko zdravljenje.
English: INDICATION(S) Acute and chronic musculo-skeletal disorders.
Slovenian: INDIKACIJA(E) Akutna in kronična mišično-skeletna obolenja.
English: Do not use in pregnant or lactating dogs.
Slovenian: Ne uporabljajte pri brejih ali doječih psicah.
English: Turn the bottle syringe upside down.
Slovenian: Stekleničko z brizgalko obrnite navzdol.
English: Shelf life after first opening the container: 6 months.
Slovenian: Rok uporabnosti po prvem odprtju vsebnika: 6 mesecev.
English: Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Slovenian: Izogibajte se uporabi pri psih z dehidracijo, hipovolemijo ali hipotenzijo, saj obstaja tveganje za povečano renalno toksičnost.
English: The suspension of the 10 ml pack size could be administered using the smallest syringe for dogs less than 8 kg body weight (one graduation corresponding to 0.5 kg of body weight) or the largest syringe for dogs over than 8 kg body weight (one graduation corresponding to 2.0 kg of body weight).
Slovenian: Suspenzija v pakiranju po 10 ml se lahko odmeri s pomočjo manjše brizgalke za pse, ki so lažji od 8 kg (en razdelek odgovarja 0,5 kg telesne mase) ali s pomočjo večje brizgalke za pse, ki so težji od 8 kg (en razdelek odgovarja 2,0 kg telesne mase).
English: The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.
Slovenian: Poleg tega je treba pri določanju obdobja brez zdravil upoštevati tudi farmakokinetične lastnosti zdravil, ki so bila uporabljena predhodno.
English: Do not use after the expiry date stated on the label and carton after EXP.
Slovenian: Ne uporabljajte po datumu izteka roka uporabnosti, ki sledi napisu EXP na ovojnini.
English: In very rare cases haemorrhagic diarrhoea, haematemisis, gastrointestinal ulceration and elevated liver enzymes have been reported.
Slovenian: V zelo redkih primerih so poročali o hemoragični driski, hematemezi, razjedah prebavil in zvišani ravni jetrnih encimov.
English: 4.2 Indications for use, specifying the target species Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Slovenian: 4.2 Indikacije za uporabo pri ciljnih živalskih vrstah Umirjanje vnetja in lajšanje bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih pri psih.
English: In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Slovenian: V primeru nenamernega zaužitja se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali nalepko na zunanji ovojnini.
English: EXP Once opened, use within 6 months.
Slovenian: EXP: Načeto zdravilo uporabite v 6-ih mesecih.
English: Pre- treatment with anti-inflammatory substances may result in additional or increased adverse reactions and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment.
Slovenian: Predzdravljenje z zdravili s protivnetnim delovanjem lahko povzroči dodatne neželene učinke ali jih okrepi, zato teh zdravil za uporabo v veterinarski medicini ne smemo dajati najmanj 24 ur pred začetkom zdravljenja.
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each ml contains:
Slovenian: NAVEDBA ZDRAVILNE(IH) UČINKOVIN(E) IN DRUGIH SNOVI Vsak ml vsebuje:
English: The suspension has to be given with the measuring syringe provided in the package.
Slovenian: Suspenzijo je treba odmeriti z odmerno brizgalko, ki je sestavni del pakiranja.
English: Microcrystalline cellulose Xxanthan gum Carboxymethylcellulose Sodium benzoate Sodium saccharinate
Slovenian: Seznam pomožnih snovi mikrokristalinska celuloza ksantan gumi karboksimetilceluloza natrijev benzoat natrijev saharinat glicerol sorbitol monohidrat citronske kisline natrijev hidroksid prečiščena voda
English: PACKAGE SIZE 150 ml
Slovenian: VELIKOST PAKIRANJA 150 ml
English: Meloxivet must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Slovenian: Meloxiveta ne smemo dajati skupaj z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box for bottle 10, 30 and 150 ml
Slovenian: PODATKI NA ZUNANJI OVOJNINI Kartonska škatla za stekleničke po 10, 30 in 150 ml
English: After each dose, the tip of the syringe should be wiped and the bottle cap screwed back on tightly.
Slovenian: Po vsakem odmerku je treba vrh brizgalke obrisati in pokrovček trdno priviti na stekleničko.